These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38237708)

  • 1. Overcoming intestinal barriers by heparanase-responsive charge-converting nanocarriers.
    Veider F; Zöller K; Saleh A; Bernkop-Schnürch A
    Int J Pharm; 2024 Feb; 651():123817. PubMed ID: 38237708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge converting nanostructured lipid carriers containing a cell-penetrating peptide for enhanced cellular uptake.
    Knoll P; Hörmann N; Nguyen Le NM; Wibel R; Gust R; Bernkop-Schnürch A
    J Colloid Interface Sci; 2022 Dec; 628(Pt A):463-475. PubMed ID: 35932682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral drug delivery: Influence of mucus on cellular interactions and uptake of lipid-based nanocarriers in Caco-2 cells.
    Veider F; Knoll P; Jörgensen AM; Stengel D; Bernkop-Schnürch A
    Acta Biomater; 2023 Sep; 167():416-424. PubMed ID: 37311506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of nanostructured lipid carriers and solid lipid nanoparticles for enhanced cellular uptake.
    Veider F; Akkuş-Dağdeviren ZB; Knoll P; Bernkop-Schnürch A
    Int J Pharm; 2022 Aug; 624():122014. PubMed ID: 35850184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate decorated lipid-based nanocarriers providing a prolonged mucosal residence time.
    Efiana NA; Fürst A; Saleh A; Shahzadi I; Bernkop-Schnürch A
    Int J Pharm; 2022 Sep; 625():122096. PubMed ID: 35963286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.
    Beloqui A; Solinís MÁ; des Rieux A; Préat V; Rodríguez-Gascón A
    Int J Pharm; 2014 Jul; 468(1-2):105-11. PubMed ID: 24746410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoarchitectonics of Layer-by-Layer (LbL) coated nanostructured lipid carriers (NLCs) for Enzyme-Triggered charge reversal.
    Akkuş-Dağdeviren ZB; Fürst A; David Friedl J; Tribus M; Bernkop-Schnürch A
    J Colloid Interface Sci; 2023 Jan; 629(Pt A):541-553. PubMed ID: 36088699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide?
    Dumont C; Beloqui A; Miolane C; Bourgeois S; Préat V; Fessi H; Jannin V
    Int J Pharm; 2020 Aug; 586():119581. PubMed ID: 32603838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diethylene glycol monoethyl ether-mediated nanostructured lipid carriers enhance
    Zhang H; Guo J; Wang Z; Wang N; Feng N; Zhang Y
    Acta Pharm; 2023 Mar; 73(1):133-143. PubMed ID: 36692464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEG vs. zwitterions: How these surface decorations determine cellular uptake of lipid-based nanocarriers.
    Stengel D; Demirel BH; Knoll P; Truszkowska M; Laffleur F; Bernkop-Schnürch A
    J Colloid Interface Sci; 2023 Oct; 647():52-64. PubMed ID: 37244176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
    Kim CH; Sa CK; Goh MS; Lee ES; Kang TH; Yoon HY; Battogtokh G; Ko YT; Choi YW
    Int J Nanomedicine; 2018; 13():6661-6675. PubMed ID: 30425481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes.
    Truzzi E; Bongio C; Sacchetti F; Maretti E; Montanari M; Iannuccelli V; Vismara E; Leo E
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28598368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol: Isolation, and Its Nanostructured Lipid Carriers, Inhibits Cell Proliferation, Induces Cell Apoptosis in Certain Human Cell Lines Carcinoma and Exerts Protective Effect Against Paraquat-Induced Hepatotoxicity.
    Elgizawy HA; Ali AA; Hussein MA
    J Med Food; 2021 Jan; 24(1):89-100. PubMed ID: 32580673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations.
    Mura P; Maestrelli F; D'Ambrosio M; Luceri C; Cirri M
    Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33804945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced intestinal absorption of curcumin in Caco-2 cell monolayer using mucoadhesive nanostructured lipid carriers.
    Chanburee S; Tiyaboonchai W
    J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):734-741. PubMed ID: 28323388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
    Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
    ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
    Kuo YC; Chung JF
    Colloids Surf B Biointerfaces; 2011 Apr; 83(2):299-306. PubMed ID: 21194902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier.
    Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A
    Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.